Informed Implementation of Breast Density Reporting
Informed Implementation of Breast Density Reporting
ClinicalTrials.gov ID
NCT02986360
Lead Sponsor
Brigham and Women's HospitalOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
500Actual
Last Update Posted
Sep 21, 2018Actual
Start Date
May 1, 2017Actual
Primary Completion Date
Nov 30, 2017Actual
Completion Date
Nov 30, 2017Actual
Official Title
Informed Implementation of Breast Density Reporting
Brief Summary
To develop brief informational videos, Vidscrips, that can be sent to women following their mammogram to provide personalized information that integrates breast density with overall breast cancer risk, and provides information about additional care recommendations and talking tips for conversations with the health care providers.
To test the effectiveness of this tool in a trial of 300 women undergoing mammography. The investigators hypothesize that individuals in the intervention arm (vs. those in the standard care arm who receive a letter with the language required by the legislation) will have more accurate knowledge of their overall risk of breast cancer, their Mammographic Breast Density (MBD) result, more appropriate observed and intended use of additional screening [i.e., use of screening Magnetic Resonance Imaging (MRI) will be reserved only for women at high risk of breast cancer], better satisfaction with their episode of breast cancer screening, less decisional conflict about their personal decision for any additional evaluation, and less worry about breast cancer.
Breast Density, Breast Cancer Prevention
Vidscrip educational video
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
undergoing screening mammography at participating hospital facility
normal mammogram result
no prior history of Ductal carcinoma in situ (DCIS) or invasive breast cancer
must have email account
Exclusion Criteria:
non-English speaking
prior history of Ductal Carcinoma in situ (DCIS) or invasive breast cancer